Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J M Essigmann

Showing results (31-40 of 91) with videos related to

Pageof 10
Sort By:
Analytical Biochemistry|August 1, 1977
Quantitative determination of transfer RNA base composition using high-pressure liquid chromatographyJ M Essigmann, W F Busby, G N Wogan
Biochemistry|November 18, 1998
Cisplatin-DNA adducts inhibit ribosomal RNA synthesis by hijacking the transcription factor human upstream binding factorX Zhai, H Beckmann, H M Jantzen, et al.
The Journal of Biological Chemistry|February 15, 1991
Relative efficiencies of the bacterial, yeast, and human DNA methyltransferases for the repair of O6-methylguanine and O4-methylthymine. Suggestive evidence for O4-methylthymine repair by eukaryotic methyltransferasesM Sassanfar, M K Dosanjh, J M Essigmann, et al.
Biochemistry|July 31, 1990
Mechanistic studies of ionizing radiation and oxidative mutagenesis: genetic effects of a single 8-hydroxyguanine (7-hydro-8-oxoguanine) residue inserted at a unique site in a viral genomeM L Wood, M Dizdaroglu, E Gajewski, et al.
Chemistry & Biology|July 1, 1996
The mismatch-repair protein hMSH2 binds selectively to DNA adducts of the anticancer drug cisplatinJ A Mello, S Acharya, R Fishel, et al.
Biochemistry|September 11, 1990
Effect of the antitumor drug cis-diamminedichloroplatinum(II) and related platinum complexes on eukaryotic DNA replicationW J Heiger-Bernays, J M Essigmann, S J Lippard
Proceedings of the National Academy of Sciences of the United States of America|September 2, 1997
An intercalation inhibitor altering the target selectivity of DNA damaging agents: synthesis of site-specific aflatoxin B1 adducts in a p53 mutational hotspotW R Kobertz, D Wang, G N Wogan, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 7, 1994
Cisplatin-DNA adducts are molecular decoys for the ribosomal RNA transcription factor hUBF (human upstream binding factor)D K Treiber, X Zhai, H M Jantzen, et al.
Biochemistry|May 15, 1990
Comparative efficiency of forming m4T.G versus m4T.A base pairs at a unique site by use of Escherichia coli DNA polymerase I (Klenow fragment) and Drosophila melanogaster polymerase alpha-primase complexM K Dosanjh, J M Essigmann, M F Goodman, et al.
Advances in Experimental Medicine and Biology|January 5, 2002
Design of DNA damaging agents that hijack transcription factors and block DNA repairJ M Essigmann, S M Rink, H J Park, et al.
Pageof 10

Showing results (31-40 of 91) with videos related to

Sort By:
Pageof 10
Analytical Biochemistry|August 1, 1977
Quantitative determination of transfer RNA base composition using high-pressure liquid chromatographyJ M Essigmann, W F Busby, G N Wogan
Biochemistry|November 18, 1998
Cisplatin-DNA adducts inhibit ribosomal RNA synthesis by hijacking the transcription factor human upstream binding factorX Zhai, H Beckmann, H M Jantzen, et al.
The Journal of Biological Chemistry|February 15, 1991
Relative efficiencies of the bacterial, yeast, and human DNA methyltransferases for the repair of O6-methylguanine and O4-methylthymine. Suggestive evidence for O4-methylthymine repair by eukaryotic methyltransferasesM Sassanfar, M K Dosanjh, J M Essigmann, et al.
Biochemistry|July 31, 1990
Mechanistic studies of ionizing radiation and oxidative mutagenesis: genetic effects of a single 8-hydroxyguanine (7-hydro-8-oxoguanine) residue inserted at a unique site in a viral genomeM L Wood, M Dizdaroglu, E Gajewski, et al.
Chemistry & Biology|July 1, 1996
The mismatch-repair protein hMSH2 binds selectively to DNA adducts of the anticancer drug cisplatinJ A Mello, S Acharya, R Fishel, et al.
Biochemistry|September 11, 1990
Effect of the antitumor drug cis-diamminedichloroplatinum(II) and related platinum complexes on eukaryotic DNA replicationW J Heiger-Bernays, J M Essigmann, S J Lippard
Proceedings of the National Academy of Sciences of the United States of America|September 2, 1997
An intercalation inhibitor altering the target selectivity of DNA damaging agents: synthesis of site-specific aflatoxin B1 adducts in a p53 mutational hotspotW R Kobertz, D Wang, G N Wogan, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 7, 1994
Cisplatin-DNA adducts are molecular decoys for the ribosomal RNA transcription factor hUBF (human upstream binding factor)D K Treiber, X Zhai, H M Jantzen, et al.
Biochemistry|May 15, 1990
Comparative efficiency of forming m4T.G versus m4T.A base pairs at a unique site by use of Escherichia coli DNA polymerase I (Klenow fragment) and Drosophila melanogaster polymerase alpha-primase complexM K Dosanjh, J M Essigmann, M F Goodman, et al.
Advances in Experimental Medicine and Biology|January 5, 2002
Design of DNA damaging agents that hijack transcription factors and block DNA repairJ M Essigmann, S M Rink, H J Park, et al.
Pageof 10